{"database": "lobbying", "table": "lobbying_activities", "rows": [[2191022, "972b33a7-e7ce-4adf-9ac2-64e43ebee295", "Q3", "BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC", 401104621, "BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC", 2018, "third_quarter", "PHA", "HR 5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 , S. 916 - Protecting Patient Access to Emergency Medications Act of 2017: To amend the Controlled Substances Act to provide for the delivery of a controlled substance by a pharmacy to an administering practitioner.\nS.2680 - Opioid Crisis Response Act of 2018, H.R.5176 - Preventing Overdoses While in Emergency Rooms Act of 2018, H.R.6 - SUPPORT for Patients and Communities Act - all relevant sections pertaining to opioid crisis", "HOUSE OF REPRESENTATIVES,SENATE", null, 130000, 0, 0, "2018-10-18T12:02:41.350000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2191022"], "units": {}, "query_ms": 34.20022298814729, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}